BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32185576)

  • 1. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
    Minniti G; Clarke E; Lanzetta G; Osti MF; Trasimeni G; Bozzao A; Romano A; Enrici RM
    Radiat Oncol; 2011 May; 6():48. PubMed ID: 21575163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionated stereotactic radiosurgery for patients with brain metastases.
    Minniti G; D'Angelillo RM; Scaringi C; Trodella LE; Clarke E; Matteucci P; Osti MF; Ramella S; Enrici RM; Trodella L
    J Neurooncol; 2014 Apr; 117(2):295-301. PubMed ID: 24488446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
    J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
    Blonigen BJ; Steinmetz RD; Levin L; Lamba MA; Warnick RE; Breneman JC
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):996-1001. PubMed ID: 19783374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.
    Märtens B; Janssen S; Werner M; Frühauf J; Christiansen H; Bremer M; Steinmann D
    BMC Cancer; 2012 Oct; 12():497. PubMed ID: 23098039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach.
    Steinmann D; Maertens B; Janssen S; Werner M; Frühauf J; Nakamura M; Christiansen H; Bremer M
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1523-9. PubMed ID: 22526164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation.
    Eaton BR; Gebhardt B; Prabhu R; Shu HK; Curran WJ; Crocker I
    Radiat Oncol; 2013 Jun; 8():135. PubMed ID: 23759065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
    Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
    Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.
    Doğan B; Demir H; Işık N; Gunalp G; Günbey HP; Yaprak G
    Br J Radiol; 2024 May; 97(1157):1022-1028. PubMed ID: 38426391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects.
    Diao K; Bian SX; Routman DM; Yu C; Kim PE; Wagle NA; Wong MK; Zada G; Chang EL
    J Neurosurg; 2018 Dec; 129(6):1397-1406. PubMed ID: 29303446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors.
    Ogura K; Mizowaki T; Ogura M; Sakanaka K; Arakawa Y; Miyamoto S; Hiraoka M
    J Neurooncol; 2012 Sep; 109(2):425-32. PubMed ID: 22714054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
    Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
    Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of moderately dosed radiosurgery for limited brain metastases. Report of a single-center experience.
    Meisner J; Meyer A; Polivka B; Karstens JH; Bremer M
    Strahlenther Onkol; 2010 Feb; 186(2):76-81. PubMed ID: 20127224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.
    Ohtakara K; Hayashi S; Nakayama N; Ohe N; Yano H; Iwama T; Hoshi H
    J Neurooncol; 2012 May; 108(1):201-9. PubMed ID: 22392126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
    Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
    Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
    Radiother Oncol; 2006 Oct; 81(1):18-24. PubMed ID: 16978720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated stereotactic radiosurgery for large brain metastases.
    Wegner RE; Leeman JE; Kabolizadeh P; Rwigema JC; Mintz AH; Burton SA; Heron DE
    Am J Clin Oncol; 2015 Apr; 38(2):135-9. PubMed ID: 23563213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
    Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
    J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
    Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.